DeepMed Research

The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Phase 2

Recruiting

Conditions: Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions: Biological: Ipilimumab
Drug: Cabozantinib
Biological: Nivolumab

First Posted Date: 2022-05-05

Last Posted Date: 2024-07-17

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 54

Registration Number: NCT05361720

Locations: 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
🇺🇸
University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States

and more 3 locations

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

Phase 4

Completed

Conditions: Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma

Interventions: Procedure: Telemedicine Visit
Procedure: Vital sign measurements
Procedure: Out-Patient Clinic Visit
Procedure: Blood pressure and pulse oximeter
Biological: Axicabtagene Ciloleucel
Drug: Cyclophosphamide
Drug: Fludarabine

First Posted Date: 2021-11-05

Last Posted Date: 2025-03-27

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 25

Registration Number: NCT05108805

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Completed

Conditions: Renal Cell Carcinoma

Interventions: Other: Blood collection
Other: Urine collection

First Posted Date: 2021-05-12

Last Posted Date: 2024-10-22

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 180

Registration Number: NCT04883827

Locations: 🇺🇸
Tennessee Valley Health Care System, Nashville, Tennessee, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Improving Care After Inherited Cancer Testing

Not Applicable

Recruiting

Conditions: Inherited Cancer Syndrome
Prostate Cancer
Endometrial Cancer
Colorectal Cancer
Breast Cancer

Interventions: Other: Correlative Studies (Survey)
Other: Correlative Studies (Interview)
Other: Access to Education Materials
Behavioral: Standard-of-care & Adaptive Intervention
Behavioral: GeneSHARE
Behavioral: LivingLabReport

First Posted Date: 2021-02-21

Last Posted Date: 2025-04-01

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 720

Registration Number: NCT04763915

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Metabolism Informed Smoking Treatment: The MIST RCT

Phase 3

Completed

Conditions: Smoking

Interventions: Behavioral: Post-discharge automated phone calls (IVR) with option to connect with a tobacco coach.
Drug: Nicotine Replacement Therapy
Drug: Varenicline
Other: Metabolism Informed Smoking Treatment (Nicotine metabolite ratio (NMR)-based selection of pharmacotherapy)

First Posted Date: 2020-10-19

Last Posted Date: 2025-05-09

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 608

Registration Number: NCT04590404

Locations: 🇺🇸
Vanderbilt University Medical Center ViTAL, Vanderbilt Center for Tobacco, Addiction, and Lifestyle General Internal Medicine and Public Health 2525 West End Ave, Suite 450, Nashville, Tennessee, United States

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Phase 2

Recruiting

Conditions: Soft Tissue Sarcomas

Interventions: Radiation: Ultra-Hypo-fractionation Radiotherapy
Procedure: Resection
Radiation: Moderately-Hypo-fractionation Radiotherapy
Other: Questionnaire Administration

First Posted Date: 2020-08-10

Last Posted Date: 2025-03-28

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 40

Registration Number: NCT04506008

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Phase 1

Active, not recruiting

Conditions: Metaplasia
Stage I Gastric Cancer
Initial-onset Gastric Cancer
Gastric Cancer

Interventions: Drug: Trametinib treatment
Procedure: Endoscopy

First Posted Date: 2020-07-01

Last Posted Date: 2024-07-31

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 15

Registration Number: NCT04454476

Locations: 🇯🇵
Nagasaki University Hospital, Nagasaki, Japan
🇯🇵
University of Tokyo Medical Center, Tokyo, Japan
🇯🇵
Nihon University School of Medicine, Tokyo, Japan

COVID-19 and Cancer Consortium Registry

Active, not recruiting

Conditions: Invasive Malignancy (Any Type)
COVID-19

First Posted Date: 2020-04-21

Last Posted Date: 2024-01-09

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 19275

Registration Number: NCT04354701

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Phase 2

Terminated

Conditions: Thyroid Carcinoma
Radioactive Iodine Level

Interventions: Drug: Artificial Tears

First Posted Date: 2020-03-31

Last Posted Date: 2024-01-18

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 9

Registration Number: NCT04327999

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Not Applicable

Completed

Conditions: Refractory Cancer
Advanced Cancer
Relapsed Cancer

Interventions: Behavioral: Animal-Assisted Interactions

First Posted Date: 2020-03-17

Last Posted Date: 2024-08-19

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 74

Registration Number: NCT04310345

Locations: 🇺🇸
Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy